Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Burning Rock Biotech Ltd ADR (BNR)

Burning Rock Biotech Ltd ADR (BNR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Burning Rock Biotech Ltd ADR NO. 5 XINGDAO RING ROAD NORTH INTERNATIONAL BIO ISLAND GUANGZHOU GUANGDONG F4 510005 CHN

www.brbiotech.com Employees: 674 P: 86-185-0164-1666 F: 203-403-7872

Description:

Burning Rock Biotech Limited focuses on the application of next generation sequencing technology in the field of precision oncology. Its business consists of NGS-based therapy selection testing for late-stage cancer patients as well as NGS-based cancer early detection. Burning Rock Biotech Limited is based in GUANGZHOU, China.

Key Statistics

Overview:

Market Capitalization, $K 344,459
Enterprise Value, $K 272,919
Shares Outstanding, K 10,761
Float, K 7,500
% Float 69.70%
Short Interest, K 47
Short Float 0.43%
Days to Cover 1.00
Short Volume Ratio 0.37
% of Insider Shareholders 30.30%
% of Institutional Shareholders 30.03%

Financials:

Annual Sales, $ 70,670 K
Annual Net Income, $ -47,490 K
Last Quarter Sales, $ 18,490 K
Last Quarter Net Income, $ -2,360 K
EBIT, $ -11,910 K
EBITDA, $ -4,760 K

Growth:

1-Year Return 390.20%
3-Year Return -4.73%
5-Year Return -91.26%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.26 on 11/20/25
Next Earnings Date 03/24/26
Earnings Per Share ttm -1.66
EPS Growth vs. Prev Qtr -73.33%
EPS Growth vs. Prev Year 48.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 05/15/24

BNR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -21.26%
Return-on-Assets % -14.27%
Profit Margin % -67.20%
Debt/Equity 0.00
Price/Sales 4.41
Price/Cash Flow N/A
Price/Book 4.64
Book Value/Share 7.17
Interest Coverage -0.30
60-Month Beta 1.25
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar